Cargando…
Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile
Lung cancer is a very aggressive cancer characterized with molecular heterogeneities in different subtypes, including lung adenocarcinoma and lung squamous cell carcinoma. However, few related molecular signatures have been established for the treatment of lung cancer subtypes. Polo‐like kinase (PLK...
Autores principales: | Deng, Sisi, Lu, Xiaoli, Zhang, Zhi, Meng, Rui, Li, Mi, Xia, Shilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278123/ https://www.ncbi.nlm.nih.gov/pubmed/34080290 http://dx.doi.org/10.1111/jcmm.16668 |
Ejemplares similares
-
Systemic analyses of expression patterns and clinical features for GIMAPs family members in lung adenocarcinoma
por: Deng, Sisi, et al.
Publicado: (2020) -
Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma
por: Wu, Xiaohong, et al.
Publicado: (2020) -
PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma
por: Wang, Lina, et al.
Publicado: (2022) -
Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling
por: Lu, Chaojing, et al.
Publicado: (2016) -
Integrative Analysis of Methylation and Gene Expression in Lung Adenocarcinoma and Squamous Cell Lung Carcinoma
por: Zhang, Hao, et al.
Publicado: (2020)